Roche Expands Cyclospora Testing Portfolio To Support U.S. Public Health Response

Roche introduced two real-time PCR assays to improve real-time laboratory detection of Cyclospora cayetanensis, aiming to strengthen diagnosis for a parasite associated with severe gastrointestinal illness. The update is product-focused and likely modest for near-term financials, with limited expected market impact.

Analysis

Roche introduced two real-time PCR assays to improve real-time laboratory detection of Cyclospora cayetanensis, aiming to strengthen diagnosis for a parasite associated with severe gastrointestinal illness. The update is product-focused and likely modest for near-term financials, with limited expected market impact.